Skip to main content

Main navigation

  • Schizophrenia Foundations
  • Symptomatology
  • Patient Burden
  • Caregiver Perspectives
  • Psychopharmacology

Main navigation

  • Schizophrenia Foundations
  • Symptomatology
  • Patient Burden
  • Caregiver Perspectives
  • Psychopharmacology

Can Peripherally Restricted Anticholinergics Like Trospium Reduce Risks?

September 17, 2025

HMP · Can Peripherally Restricted Anticholinergics Like Trospium Reduce Risks?

Welcome to Schizophrenia Knowledge Base

This website is intended for healthcare professionals in the United States.

Yes, I am a US healthcare professional
No, I am not a US healthcare professional

Greg Mattingly, MD examines safer alternatives and their limitations.

Related Content

Treatment Options and Managing Side Effects in Schizophrenia
What’s the Role of Amantadine in Anticholinergic Deprescription?
Understanding the Cholinergic System
Anticholinergic Misuse: Can These Medications Be Addictive?
Can Peripherally Restricted Anticholinergics Like Trospium Reduce Risks?
Assessing Anticholinergic Burden
Case Managers, Telepsychiatry Offer Consistency in Schizophrenia Treatment
© 2025 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use Cookie Policy